Antiviral activity of Sonchus arvensis L. extracts on dengue virus replication

Abstract

Objective: To investigate the antiviral potential of Sonchus arvensis L. extracts against dengue virus (DENV)-1 and DENV-2 in vitro, and elucidate its underlying antiviral mechanisms.
Methods: The cytotoxicity of the ethanol, ethyl acetate, and n-hexane extracts of Sonchus arvensis L. was determined using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay, followed by post-treatment antiviral assays. Multiple treatment regimens were conducted to assess antiviral effects at different stages of the DENV replication cycle. qRT-PCR analysis was performed to evaluate the effects of the ethanol extract on genes associated with host innate immune and inflammatory responses.
Results: The CC₅₀ values of the ethanol, ethyl acetate, and n-hexane extracts were 391.5 μg/mL, 104.9 μg/mL, and 409.2 μg/mL, respectively. The ethanol and ethyl acetate extracts reduced DENV-1 and DENV-2 titers by >90% at 30-50 μg/mL, while the n-hexane extract showed comparable activity against DENV-2. The ethanol extract at 30 μg/mL demonstrated potent multi-stage antiviral activity, including direct virucidal, prophylactic, anti-adsorption, and anti-internalization effects. qRT-PCR analysis revealed no significant change in IFN-β expression but marked suppression of NF-κB, TNF-α, and IL-6 expression.
Conclusions: Sonchus arvensis L. ethanol extracts demonstrate potent multi-stage antiviral activity against DENV in vitro, highlighting its ability to inhibit viral entry, reduce viral replication, and attenuate excessive inflammatory responses.

Keywords

Antiviral / Dengue / Dengue virus / Sonchus arvensis L. / Anti-inflammatory / NF-κB

References

[1] Sarker R, Roknuzzaman ASM, Haque MA, Islam MR, Kabir ER. Upsurge of dengue outbreaks in several WHO regions: Public awareness, vector control activities, and international collaborations are key to prevent spread. Health Sci Rep 2024; 7(4): e2034.

[2] Uno N, Ross TM. Dengue virus and the host innate immune response. Emerg Microbes Infect 2018; 7(1): 1-11.

[3] Sinha S, Singh K, Ravi Kumar YS, Roy R, Phadnis S, Meena V, et al. Dengue virus pathogenesis and host molecular machineries. J Biomed Sci 2024; 31(1): 43.

[4] Junjhon J, Pennington JG, Edwards TJ, Perera R, Lanman J, Kuhn RJ. Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells. J Virol 2014; 88(9): 4687-4697.

[5] Dhole P, Zaidi A, Nariya HK, Sinha S, Jinesh S, Srivastava S. Host immune response to Dengue virus infection: Friend or foe? Immuno 2024; 4(4): 549-577.

[6] Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R. NF-κB: At the borders of autoimmunity and inflammation. Front Immunol 2021; 12: 716469.

[7] Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017; 2: 17023.

[8] Hiscott J, Kwon H, Génin P. Hostile takeovers: Viral appropriation of the NF-κB pathway. J Clin Invest 2001; 107(2): 143-151.

[9] Izmirly AM, Alturki SO, Alturki SO, Connors J, Haddad EK. Challenges in dengue vaccines development: Pre-existing infections and cross-reactivity. Front Immunol 2020; 11: 1055.

[10] Tayal A, Kabra SK, Lodha R. Management of dengue: An updated review. Indian J Pediatr 2023; 90: 168-177.

[11] Alagarasu K, Patil P, Kaushik M, Chowdhury D, Joshi RK, Hegde HV, et al. In vitro antiviral activity of potential medicinal plant extracts against dengue and Chikungunya viruses. Front Cell Infect Microbiol 2022; 12: 866452.

[12] Rehman B, Ahmed A, Khan S, Saleem N, Naseer F, Ahmad S. Exploring plant-based dengue therapeutics: From laboratory to clinic. Trop Dis Travel Med Vaccines 2024; 10(1): 23.

[13] Sonchus arvensis (perennial sowthistle). In: CABI Compend 2021. Wallingford (UK): CABI; 2021. [Online] Available from: http://www.cabidigitallibrary.org/doi/10.1079/cabicompendium.50583 [Accessed on 8 June 2025].

[14] Tandi J, Nyoman Edi Sutrisna I, Pratiwi M, Handayani TW. Potential test of nephropathy Sonchus arvensis L. leaves on male rats (Rattus norvegicus) diabetes mellitus. Pharmacogn J 2020; 12(5): 1115-1120.

[15] Parisa N, Hidayat R, Maritska Z, Prananjaya BA. Evaluation of the antigout effect of Sonchus arvensis on monosodium urate crystal-induced gout arthritis via anti-inflammatory action-an in vivo study. Med Pharm Rep 2021; 94(3): 358-365.

[16] Wahyuni DK, Wacharasindhu S, Bankeeree W, Punnapayak H, Purnobasuki H, Junairiah, et al. Molecular simulation of compounds from n-hexane fraction of Sonchus arvensis L. leaves as SARS-CoV-2 antiviral through inhibitor activity targeting strategic viral protein. J Pharm Pharmacogn Res 2022; 10(6): 1126-1138.

[17] Begum F, Das S, Mukherjee D, Mal S, Ray U. Insight into the tropism of dengue virus in humans. Viruses 2019; 11(12): 1136.

[18] Teoh BT, Sam SS, Tan KK, Johari J, Shu MH, Danlami MB, et al. Dengue virus type 1 clade replacement in recurring homotypic outbreaks. BMC Evol Biol 2013; 13(1): 213.

[19] Maryam M, Te KK, Wong FC, Chai TT, Low GKK, Gan SC, et al. Antiviral activity of traditional Chinese medicinal plants Dryopteris crassirhizoma and Morus alba against dengue virus. J Integr Agric 2020; 19(4): 1085-1096.

[20] Mohd A, Zainal N, Tan KK, AbuBakar S. Resveratrol affects Zika virus replication in vitro. Sci Rep 2019; 9(1): 14336.

[21] Zulkefle NN, Zainal N, Wahyuni DK, Mahmood S, Ramarao KDR, Chin KL. Antimicrobial properties of Sonchus species: A review. Asian Pac J Trop Biomed 2025; 15(5): 177-188.

[22] Kuete V, Karaosmanoğlu O, Sivas H. Anticancer activities of African medicinal spices and vegetables. In: Kuete V (ed). Medicinal spices and vegetables from Africa: Therapeutic potential against metabolic, inflammatory, infectious and systemic diseases. Amsterdam: Academic Press; 2017, p. 271-297.

[23] Akter S, Addepalli R, Netzel ME, Tinggi U, Fletcher MT, Sultanbawa Y, et al. Antioxidant-rich extracts of Terminalia ferdinandiana interfere with estimation of cell viability. Antioxidants 2019; 8(6): 191.

[24] Jayasekara KG, Soysa P, Suresh TS, Goonasekara CL, Gunasekera KM. In vitro dengue virus inhibition by aqueous extracts of Aegle marmelos, Munronia pinnata and Psidium guajava. Altern Lab Anim 2023; 51(2): 136-143.

[25] Wahyuni DK, Wacharasindhu S, Bankeeree W, Wahyuningsih SPA, Ekasari W, Purnobasuki H, et al. In vitro and in vivo antiplasmodial activities of leaf extracts from Sonchus arvensis L. BMC Complement Med Ther 2023; 23(1): 47.

[26] Riss TL, Moravec RA. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol 2004; 2(1): 51-62.

[27] Indrayanto G, Putra GS, Suhud F. Validation of in-vitro bioassay Methods: Application in herbal drug research. Profiles Drug Subst Excip Relat Methodol 2021; 46: 273-307.

[28] Nazaruddin, Rosmaidar, Siregar TN, Wahyuni S, Sutriana A. Phytocomponents analysis and antioxidant activity of Malacca fruit extract (Phyllanthus emblica) using three different solvents. Biodiversitas 2024; 25(5): 1911-1919.

[29] Dhanaraj FI, Kalimuthu JK, Balamurugan PS, Subramani P, Katerere DR, Gurusamy M. Investigating the phytochemical profile and antioxidant activity of different solvent extracts of Sesamum prostratum Retz. Plants 2025; 14(4): 519.

[30] Yaseen G, Ahmad M, Zafar M, Akram A, Sultana S, Kilic O, et al. Current status of solvents used in the pharmaceutical industry. In: Inamuddin, Boddula R, Ahamed MI, Asiri AM (eds). Green sustainable process for chemical and environmental engineering and science. Amsterdam: Elsevier; 2021, p. 195-219.

[31] Joana Gil-Chávez G, Villa JA, Fernando Ayala-Zavala J, Basilio Heredia J, Sepulveda D, Yahia EM, et al. Technologies for extraction and production of bioactive compounds to be used as nutraceuticals and food ingredients: An overview. Compr Rev Food Sci Food Saf 2013; 12(1): 5-23.

[32] Blacksell SD, Jarman RG, Bailey MS, Tanganuchitcharnchai A, Jenjaroen K, Gibbons RV, et al. Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: The need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin Vaccine Immunol 2011; 18(12): 2095-2101.

[33] Czuppon P, Débarre F, Gonçalves A, Tenaillon O, Perelson AS, Guedj J, et al. Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS Comput Biol 2021; 17(3): e1008752.

[34] Soriano V, Treviño A, de Mendoza C, Moreno-Torres V, Pintos I, Barreiro P, et al. Pre-exposure prophylaxis for viral infections other than HIV. Infez Med 2022; 30(3): 362-371.

[35] Mir A, Ismatullah H, Rauf S, Niazi UHK. Identification of bioflavonoid as fusion inhibitor of dengue virus using molecular docking approach. Inform Med Unlocked 2016; 3: 1-6.

[36] Jayadevappa MK, Karkera PR, Siddappa RY, Telkar S, Karunakara P. Investigation of plant flavonoids as potential dengue protease inhibitors. J Herbmed Pharmacol 2020; 9(4): 366-373.

[37] Yang J, Song X, Hu H, Zhong W, Cao R, Xu Y, et al. Chemical composition and antifungal, anti-inflammatory, antiviral, and larvicidal activities of the essential oils of Zanthoxylum acanthopodium DC. from China and Myanmar. Molecules 2022; 27(16): 5243.

[38] Pagni S, Fernandez-Sesma A. Evasion of the human innate immune system by dengue virus. Immunol Res 2012; 54(1-3): 152-159.

[39] Angleró-Rodríguez YI, Pantoja P, Sariol CA. Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon (ε) interaction. Clin Vaccine Immunol 2014; 21(1): 29-38.

[40] Muñoz-Jordán JL, Laurent-Rolle M, Ashour J, Martínez-Sobrido L, Ashok M, Lipkin WI, et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005; 79(13): 8004-8013.

[41] Ashour J, Laurent-Rolle M, Shi PY, García-Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 2009; 83(11): 5408-5418.

[42] Gunasekera AM, Eranthaka U, Priyankara D, Kalupahana R. A rare case of acute liver failure with intrahepatic cholestasis due to dengue hemorrhagic fever: CytoSorb® and plasma exchange aided in the recovery: case report. BMC Infect Dis 2022; 22(1): 938.

[43] Yadav G, Singh P, Bedi N, Yadav S, Agrawal P. Expanded dengue syndrome: A case series. J Nepal Paediatr Soc 2025; 45(2): 38-43.

[44] Duran A, Valero N, Mosquera J, Fuenmayor E, Alvarez-Mon M. Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures. Life Sci 2017; 191: 180-185.